New evidence shows that small-fiber polyneuropathy, a disease in which nerves lack the fatty substance that covers and protects them, or the myelin sheath, may underlie some cases labeled as fibromyalgia. SFPN is a disease that can be objectively tested for and treated definitively.
The study evaluated 27 fibromyalgia patients, their scores for Michigan Neuropthy Screening Instruments and Utah Early Neuropathy Scale were higher than those of the control group.
All fibromyalgia subjects had a documented diagnosis and satisfied criteria for the American College of Rheumatology.
Powered by Facebook Comments